Citation Impact
Citing Papers
Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis
2008 Standout
A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck
2006
Head and neck cancers—major changes in the American Joint Committee on cancer eighth edition cancer staging manual
2017 Standout
Continuous accelerated 7-days-a-week radiotherapy for head-and-neck cancer: Long-term results of Phase III clinical trial
2006
The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results
2008 Standout
Aloe Vera for Preventing Radiation-induced Skin Reactions: A Systematic Literature Review
2005
Repopulation of cancer cells during therapy: an important cause of treatment failure
2005
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
An Evaluation of the Biological and Toxicological Properties ofAloe Barbadensis(Miller), Aloe Vera
2006 Standout
Altered fractionation and combined radio-chemotherapy approaches
2003
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis
2006 Standout
Drug penetration in solid tumours
2006 Standout
Head and neck cancer
2008 Standout
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
The immune contexture in cancer prognosis and treatment
2017 Standout
Merkel cell carcinoma
2017
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
2009 Standout
Results of a prospective randomised trial comparing conventional radiotherapy to split course bifractionated radiation therapy in patients with nasopharyngeal carcinoma
2007
Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data
2009
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
2006 Standout
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
Merkel Cell Carcinoma: 30-Year Experience from a Single Institution
2012
Effects of plant sterols derived from Aloe vera gel on human dermal fibroblasts in vitro and on skin condition in Japanese women
2015
Nasopharyngeal carcinoma
2015 Standout
Critical Analysis of Bladder Sparing with Trimodal Therapy in Muscle-invasive Bladder Cancer: A Systematic Review
2014
Bladder cancer
2016 Standout
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
2016 Standout
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
2010 Standout
Aloe vera: A short review
2008 Standout
Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial
2003
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
2016 Standout
Ethnobotanical survey of usage of fresh medicinal plants in Singapore
2014 Standout
Locoregionally advanced carcinoma of the oropharynx: conventional radiotherapy vs. accelerated hyperfractionated radiotherapy vs. concomitant radiotherapy and chemotherapy—a multicenter randomized trial
2002
Concomitant radiochemotherapy or accelerated radiotherapy: Analysis of two randomized trials of the French Head and Neck Cancer Group (GORTEC)
2004
Evaluation of biological properties and clinical effectiveness of Aloe vera: A systematic review
2014 Standout
Does aqueous or sucralfate cream affect the severity of erythematous radiation skin reactions? A randomised controlled trial
2004
Radiotherapy for cancer of the head and neck: altered fractionation regimens
2002
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients
2009 Standout
MERKEL CELL CARCINOMA: IMPROVED OUTCOME WITH ADJUVANT RADIOTHERAPY
2005
Cancer as an evolutionary and ecological process
2006 Standout
Phase II double-blind randomized study comparing oral aloe vera versus placebo to prevent radiation-related mucositis in patients with head-and-neck neoplasms
2004
Angiogenesis as a therapeutic target
2005 StandoutNature
Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer
2007 Standout
Effects of <b><i>Aloe</i></b> Sterol Supplementation on Skin Elasticity, Hydration, and Collagen Score: A 12-Week Double-Blind, Randomized, Controlled Trial
2016 Standout
Drug Resistance and the Solid Tumor Microenvironment
2007 Standout
The Role of Selenium in Inflammation and Immunity: From Molecular Mechanisms to Therapeutic Opportunities
2011 Standout
Composition and Applications of Aloe vera Leaf Gel
2008 Standout
Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity
2022 StandoutNobel
Lymphedema management in head and neck cancer
2010
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Bladder Cancer
2020 Standout
Outcomes of Primary Cutaneous Squamous Cell Carcinoma With Perineural Invasion
2013
Merkel Cell Carcinoma: Prognosis and Treatment of Patients From a Single Institution
2005
Editorial introductions
2010
The Control of Prostate-Specific Antigen Expression and Gene Regulation by Pharmacological Agents
2001
15-year survival rates after transurethral resection and radiochemotherapy or radiation in bladder cancer treatment.
2011
Incidence Trends for Human Papillomavirus–Related and –Unrelated Oral Squamous Cell Carcinomas in the United States
2008 Standout
Merkel Cell Carcinoma: Chemotherapy and Emerging New Therapeutic Options
2013
Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
2008 Standout
Phase III Randomized Trial of Very Accelerated Radiation Therapy Compared With Conventional Radiation Therapy in Squamous Cell Head and Neck Cancer: A GORTEC Trial
2006
Works of Jacqui Keller being referenced
Factors Influencing Relapse-Free Survival in Merkel Cell Carcinoma of the Lower Limb—A Review of 60 Cases
2009
Predictors of acute grade 4 swallowing toxicity in patients with stages III and IV squamous carcinoma of the head and neck treated with radiotherapy alone
2008
Analysis of toxicity of Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group study
2001
A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group Study
2001
Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: A report of two sequential Phase II studies from the Trans Tasman Radiation Oncology Group
2006
Weekly Carboplatin Reduces Toxicity During Synchronous Chemoradiotherapy for Merkel Cell Carcinoma of Skin
2008
Perineural Infiltration of Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma Without Clinical Features
2010
A Phase III Study on the Efficacy of Topical Aloe Vera Gel on Irradiated Breast Tissue
2002
Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin?
2005
The effect of anaemia on efficacy and normal tissue toxicity following radiotherapy for locally advanced squamous cell carcinoma of the head and neck
2003
Phase II evaluation of bolus gallium nitrate in lymphoproliferative disorders: a Southeastern Cancer Study Group trial.
1986
High-Risk Merkel Cell Carcinoma of the Skin Treated With Synchronous Carboplatin/Etoposide and Radiation: A Trans-Tasman Radiation Oncology Group Study—TROG 96:07
2003